Movement Alert｜Tango Therapeutics Falls 8.44% in Regular Trading, Trading at $28.56

Market Focus07-14

On July 14, Tango Therapeutics fell 8.44% in regular trading, trading at $28.56 USD/share, with Turnover of $41.05 million.

Within the Biotechnology sector where Tango Therapeutics belongs, individual stocks showed mixed performance. Among individual stocks, Agenus up 98.21%, Q32 Bio Inc. up 74.84%, Alnylam Pharmaceuticals down 4.05%, AbbVie down 0.49%, Moderna, Inc. down 0.76%.

Tango Therapeutics, Inc. is a clinical-stage biotechnology company committed to discovering and developing drugs for the treatment of cancer using synthetic lethality principles. Its lead program is vopimetostat, a PRMT5 inhibitor being developed for cancers with MTAP deletions, which the company is advancing toward Phase 3 trials in pancreatic cancer.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1118245449?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-07-14 02:02","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1118245449","market":"us","top_or_hot":-1,"title":"Movement Alert｜Tango Therapeutics Falls 8.44% in Regular Trading, Trading at $28.56","media":"Market Focus","content":"<p><p>On July 14, Tango Therapeutics fell 8.44% in regular trading, trading at $28.56 USD/share, with Turnover of $41.05 million.</p><p>Within the Biotechnology sector where Tango Therapeutics belongs, individual stocks showed mixed performance. Among individual stocks, Agenus up 98.21%, Q32 Bio Inc. up 74.84%, Alnylam Pharmaceuticals down 4.05%, AbbVie down 0.49%, Moderna, Inc. down 0.76%.</p><p>Tango Therapeutics, Inc. is a clinical-stage biotechnology company committed to discovering and developing drugs for the treatment of cancer using synthetic lethality principles. Its lead program is vopimetostat, a PRMT5 inhibitor being developed for cancers with MTAP deletions, which the company is advancing toward Phase 3 trials in pancreatic cancer.</p><p>(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)</p></p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Movement Alert｜Tango Therapeutics Falls 8.44% in Regular Trading, Trading at $28.56</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nMovement Alert｜Tango Therapeutics Falls 8.44% in Regular Trading, Trading at $28.56\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1054767329\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/51943b2858f75e05ca2ebb144b4e626a);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Market Focus </p>\n<p class=\"h-time\">2026-07-14 02:02</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p><p>On July 14, Tango Therapeutics fell 8.44% in regular trading, trading at $28.56 USD/share, with Turnover of $41.05 million.</p><p>Within the Biotechnology sector where Tango Therapeutics belongs, individual stocks showed mixed performance. Among individual stocks, Agenus up 98.21%, Q32 Bio Inc. up 74.84%, Alnylam Pharmaceuticals down 4.05%, AbbVie down 0.49%, Moderna, Inc. down 0.76%.</p><p>Tango Therapeutics, Inc. is a clinical-stage biotechnology company committed to discovering and developing drugs for the treatment of cancer using synthetic lethality principles. Its lead program is vopimetostat, a PRMT5 inhibitor being developed for cancers with MTAP deletions, which the company is advancing toward Phase 3 trials in pancreatic cancer.</p><p>(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)</p></p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"TNGX","symbol_name":"Tango Therapeutics Inc.","start_time":0,"source_url":"","article_id":"1118245449","we_media_id":"1054767329","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1118245449","pubTimestamp":1783965776,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Market Focus","introduction":"Track stock‘s movements and relevant news","home_visible":1,"id":"1054767329","head_image":"https://static.tigerbbs.com/51943b2858f75e05ca2ebb144b4e626a"},"summary":"On July 14, Tango Therapeutics fell 8.44% in regular trading, trading at $28.56 USD/share, with Turnover of $41.05 million.Within the Biotechnology sector where Tango Therapeutics belongs, individual...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"TNGX":"Tango Therapeutics Inc."},"translate_title":"走势警报|Tango Therapeutics 常规交易下跌 8.44%，交易价格为 28.56 美元","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"TNGX":1},"content_text":"On July 14, Tango Therapeutics fell 8.44% in regular trading, trading at $28.56 USD/share, with Turnover of $41.05 million.Within the Biotechnology sector where Tango Therapeutics belongs, individual stocks showed mixed performance. Among individual stocks, Agenus up 98.21%, Q32 Bio Inc. up 74.84%, Alnylam Pharmaceuticals down 4.05%, AbbVie down 0.49%, Moderna, Inc. down 0.76%.Tango Therapeutics, Inc. is a clinical-stage biotechnology company committed to discovering and developing drugs for the treatment of cancer using synthetic lethality principles. Its lead program is vopimetostat, a PRMT5 inhibitor being developed for cancers with MTAP deletions, which the company is advancing toward Phase 3 trials in pancreatic cancer.(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"-1","news_tag":"","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.46.0","shortVersion":"4.46.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1118245449","isCrawlerRequest":true}